Validated in vitro/in vivo correlation of prolonged-release oxycodone/naloxone with differing dissolution rates in relation to gastrointestinal transit times

By Mundin Gill E   Smith Kevin J   Mysicka Jana   Heun Gerhard   Krämer Mathias   Hahn Udo   Leuner Christian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1495-1503

Informa Healthcare

Access to resources Recommend Favorite

Oxycodone/naloxone: Oxycodone-induced constipation, and interaction (first report) leading to lack of efficacy of oxycodone, in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain – results from a large observational study

By Hermanns Kai   Junker Uwe   Nolte Thomas  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 299-311

Informa Healthcare

Access to resources Recommend Favorite

Prolonged-release Oxycodone/Naloxone in Postoperative Pain Management: from a Randomized Clinical Trial to Usual Clinical Practice

By Kuusniemi K   Zöllner J   Sjövall S   Huhtala J   Karjalainen P   Kokki M   Lemken J   Oppermann J   Kokki H  

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1775-1793

Field House Publishing

Access to resources Recommend Favorite

Oxycodone/Naloxone in the Management of Patients with Pain and Opioid–Induced Bowel Dysfunction

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 124-135

Bentham Science Publishers

Access to resources Recommend Favorite